Work

An Open-label Safety, Tolerability, and Efficacy Study of Natalizumab in Adolescents With Moderately to Severely Active Crohnʼs Disease

Year: 2004

Type: article

Study design: Clinical Trial

Source: The American Journal of Gastroenterology

DOI: 10.14309/00000434-200410001-00786

Authors: J. Hyams, D. Wilson, A. Thomas, B. Mitchell, G. Daniels, S. Zanker, S. Kugathasan

Institution: Connecticut Children's Medical Center

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2978805602

FWCI: 0.357

Cites:

Cited by: 2

Related to: 10